NEW YORK, Aug.迷你倉庫 15, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:Endoscopy Devices: Applications and Global Markets.reportlinker.com/p0591405/Endoscopy-Devices-Applications-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_MedicineThis report provides:- An overview of the global market for endoscopy services and equipment by product, company, and geography.- Analyses of global market trends, with data from 2009 to 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.- Reviews of endoscope products by their various applications and trends in innovation and sales.- Examination of the competitive environment, with a special focus on how developing products and technologies are influencing the current standard of patient care.- Information for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the Endoscopy market.STUDY GOALS AND OBJECTIVESThis report provides a comprehensive analysis of the global market for endoscopy services and equipment. The report will review global markets for endoscope products by their various applications and will forecast trends in innovation and sales in these markets through the year 2018. A range of information will be discussed, including detailed analyses of emerging markets in India and Asia, new products pipelines and new applications for endoscopic technology, and overall industry trends. This information will allow the reader to evaluate and quantify the current market size for specific endoscopic technologies within the overall growing biomedical/pharmaceutical technology market. Forecasts and trends have been developed from a variety of data, including industry sources, company publications, industry benchmarks, and other data sources. Major endoscopy applications, technologies, geographies, and factors influencing the demand for endoscopy services and products will be discussed.REASONS FOR DOING THE STUDYThe overall medical device market is very large; endoscopy is a significant component of that market. For companies with an effective strategy, market opportunity awaits. However, the ability to develop an effective strategy begins where opportunity exists and ends with effective execution and capturing profit from the opportunity.The endoscopy market is positioned for significant growth in the next five years. This is due, in part, to new applications for the technology, as well as new innovations in the technology itself. The other major factor that will contribute to this growth is the recognition of this technology in emerging markets like Japan and Vietnam. Continued worldwide growth is expected in other geographic areas due to a growing middle class in countries such as India, China, Brazil and Russia.This report addresses critically important topics for analyzing a changing market dynamic, emerging players and technologies, strategies for accessing these emerging markets, and specific disease segments and geographies in order to allow allocation of resources and make effective decisions.SCOPE OF REPORTCurrent and projected endoscopy revenue forecasts during the forecast period (2013 to 2018) are discussed. Endoscopy devices require U.S. Food and Drug Administration FDA premarket manufacturing notification (PMN) approval, European Union Medical Device Directive European Conformity (CE Mark) approval, or similar approvals in other countries. Regulation on endoscopic devices is rigid in terms of proving proof of product safety and efficacy before sale to the medical community. Due to the timing of the release of this report, the figures for 2013 are estimated, except where actual results have been reported.The report includes analysis of the leading competitors, as well as emerging companies in the current worldwide endoscopy market. Profiles of the manufacturers of the leading products are analyzed, their specific product strategies are outlined, and their pipeline of products is discussed. This report looks at companies poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment. This competitive environment is examined with special focus on how developing products and technologies are influencing the current standard of patient care. Detailed profiles of the current market leaders and emerging companies are discussed in detail.Market figures are based on revenues at the manufacturers' level and are projected in 2012-dollar value. Inflation is not calculated in the projection figures.Trends are assessed based on a number of parameters, including projected sales for existing products, new product introductions, expanded indications for existing products, and finally, for projected changes in the prevalence, diagnosis, and scripting rates for certain diseases.Included in this report are forecasts by product, disease category, and by company for the period from 2013 through 2018. The report is arranged to provide an overview of the endoscopy market by product, company and geography. Forecasts are broken down by geographic region or by country. The worldwide market is analyzed and data provided for each disease sub-segment.Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.All market share data presented is on a global basis unless specifically noted.INTENDED AUDIENCEThis report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the Endoscopy market, its products, its industry participants, and its future.The importance of identifying overall market trends, product opportunities, emerging geographies, merger and acquisition (M&A) opportunities, and insights that provide guidance for sales growth or defensive moves cannot be overstated for a variety of constituents, including:Established companies in the industry shall benefit from the contents, including corporate strategy, sales and marketing, business development, and research and development.Emerging companies in this medical device segment must understand specific opportunities for out-licensing, originating from the elements of differentiation of their product or technology as compared to leading, competitive, and emerging therapies. As well, market forecasts can support investment, provided a thorough and detailed substantiation is provided for the market forecast, as is found in this study.Investment firms evaluating candidates for venture capital or hedged investments will gain insights as to the opportunity and risks that are being encountered in the industry in a product and company specific analysis.Equity analysts are provided with detailed forecasts for the next five years, substantiated by quantitative analysis that can support further analysis to product and company forecasts over the short and long run.METHODOLOGY AND INFORMATION SOURCESIn-depth interviews were conducted with leading experts in the field who are executives in companies, industry analysts, and leading medical practitioners in the field.The overall endoscopy sector is comprised of a variety of fast-growing and independent segments. For completeness, the current and forecasted markets are comprised of the total market opportunity for each respective segment. Within each subsection, there is a detailed forecast for each driving mechanism or relevant area of growth.Information to prepare this report was obtained from participating and emerging companies in the endoscopy area, the American Urological Association; the National Heart, Lung, and Blood Institute; Arthroscopy Association of North America; American Society of Gastroenterology; and American Academy of Otolaryngology. Information also came from articles published in medical journals such as the The Journal of Endoscopy, Diagnostic and Therapeutic Endoscopy, Digestive Endoscopy, Circulation, Lancet, and others. Other information originated from the World Health Organization and other government agencies, literature searches, annual reports, 10Ks, and others. Population estimates are based on those reported by the international database of the U.S. Census Bureau.Current and historical revenue figures for individual products have been sourced from company disclosures that exist in the public domain or from government sources.CHAPTER 1 INTRODUCTION 2STUDY GOALS AND OBJECTIVES 2REASONS FOR DOING THE STUDY 2SCOPE OF REPORT 2INTENDED AUDIENCE 3METHODOLOGY AND INFORMATION SOURCES 4ANALYST'S CREDENTIALS 4RELATED REPORTS 4BCC ONLINE SERVICES 5DISCLAIMER 5CHAPTER 2 SUMMARY 7SUMMARY TABLE TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($MILLIONS) 7SUMMARY FIGURE TOTAL ENDOSCOPY MARKET, BY SEGMENT, 2009-2018 ($MILLIONS) 7CHAPTER 3 OVERVIEW 10TABLE 1 GLOBAL ENDOSCOPY REVENUES OF LEADING COMPANIES, THROUGH2012 ($ MILLIONS) 11ENDOSCOPY TRENDS AND FORECAST 11THE ENDOSCOPE AND ENDOSCOPIC PROCEDURES 12THE ENDOSCOPE 12THE ENDOSCOPIC PROCEDURE 13MAJOR COMPANIES IN THE ENDOSCOPY MARKET 14TABLE 2 LEADING PLAYERS IN VARIOUS ENDOSCOPY SEGMENTS 15DRIVERS AND RESISTORS FOR THE ENDOSCOPY MARKET 16DRIVERS 16RESISTORS 17REGULATORY DEVELOPMENTS 17PHYSICIAN PAYMENTS SUNSHINE ACT 18INCREASING INFLUENCE OF GROUP PURCHASING ORGANIZATIONS (GPOS) 19COMPARATIVE EFFECTIVENESS RESEARCH (CER) 20MEDICAL DEVICE EXCISE TAX 20CHAPTER 4 MEDICAL APPLICATIONS OF ENDOSCOPY 22UROLOGY ENDOSCOPY 22TABLE 3 KIDNEY DISEASES COMMONLY MANAGED BY ENDOSCOPY 22TABLE 4 URETER DISEASES COMMONLY MANAGED BY ENDOSCOPY 22TABLE 5 BLADDER DISEASES COMMONLY MANAGED BY ENDOSCOPY 23TABLE 6 PROSTATE DISEASES COMMONLY MANAGED BY ENDOSCOPY 23TABLE 7 URETHRA DISEASES COMMONLY MANAGED BY ENDOSCOPY 23NEPHROSCOPY 23CYSTOSCOPY 24RESECTOSCOPY 24UROLOGY ENDOSCOPY INSTRUMENT TYPE AND ACCESSORIES 25INSTRUMENTS AND TYPES 25MARKET SIZE FOR UROLOGICAL DEVICES 25TABLE 8 MARKET SIZE FOR UROLOGICAL ENDOSCOPE DEVICES, THROUGH 2018 ($MILLIONS) 25MAJOR PLAYERS IN UROLOGY ENDOSCOPY MARKET 25LAPAROSCOPY 26STOMACH RESTRICTIVE PROCEDURES 26Lap Band 26Vertical-banded Gastroplasty 27CHOLECYSTECTOMY 27APPENDECTOMY 27HERNIA REPAIR 27TABLE 9 PENETRATION OF LAPAROSCOPY IN COMMON SURGICAL PROCEDURES INT儲存E U.S., 2012 (NUMBER/%) 28HAND-ASSISTED LAPAROSCOPY 28TABLE 10 COMMERCIALLY AVAILABLE MUCOSAL ABLATION THERAPY DEVICES 30LAPAROSCOPY INSTRUMENT TYPE AND ACCESSORIES 30MARKET SIZE FOR LAPAROSCOPY DEVICES 31TABLE 11 MARKET SIZE FOR LAPAROSCOPY DEVICES, THROUGH 2018 ($ MILLIONS) 31MAJOR PLAYERS IN LAPAROSCOPY MARKET 31GI ENDOSCOPY 31UPPER GI ENDOSCOPY 31DOUBLE-BALLOON ENDOSCOPY 32VIDEO CAPSULE ENDOSCOPY 33LOWER GI ENDOSCOPY 33ENDOSCOPIC MUCOSAL RESECTION (EMR) 34TABLE 12 KEY DEVICE TYPE FOR EMR PROCEDURE 35ENDOSCOPIC ULTRASOUND SURGERY (EUS) 35TABLE 13 KEY DEVICE CATEGORIES FOR ENDOSCOPIC ULTRASOUND 36ENDOSCOPIC SNAKE DEVICES 37HIGH-DEFINITION SCOPES AND NARROW BAND IMAGING 38CHROMOENDOSCOPY 38TABLE 14 CLASSIFICATION OF STAINS USED IN CHROMOENDOSCOPY 39TABLE 15 COMMERCIALLY AVAILABLE SPRAY CATHETERS 40GI ENDOSCOPY INSTRUMENT TYPE AND ACCESSORIES 40MARKET SIZE FOR OF GI ENDOSCOPY DEVICES 41TABLE 16 MARKET SIZE FOR OF GI ENDOSCOPY DEVICES, THROUGH 2018 ($MILLIONS) 41MAJOR PLAYERS IN GI ENDOSCOPY MARKET 41ARTHROSCOPY 41KNEE ARTHROSCOPY 42Types of Knee Injury 43Annual Volume of Knee Surgeries in the U.S. 43Arthroscopic Surgery for Acute Knee Injuries 44TABLE 17 KNEE LIGAMENT DAMAGE AND SURGICAL REQUIREMENTS 44Pain Management with Lavage and Debridement 45ARTHROSCOPIC SHOULDER SURGERY 45TABLE 18 PROCEDURES ROUTINELY EMPLOYED IN ARTHROSCOPIC ROTATOR CUFFSURGERY 46ADDITIONAL JOINTS WHERE ARTHROSCOPIC SURGERY IS EMPLOYED 46WRIST ARTHROSCOPY 47TABLE 19 COMMON CONDITIONS REQUIRING ARTHROSCOPIC WRIST SURGERY 47ANKLE ARTHROSCOPY 48ARTHROSCOPIC SURGERY OF THE ELBOW 49TABLE 20 SOME COMMON ELBOW DIAGNOSES REVEALED BY ARTHROSCOPICINVESTIGATION 49ARTHROSCOPIC INVESTIGATION OF THE HIP 50FEMORO-ACETABULAR IMPINGEMENT AND HIP MOBILITY 50ARTHROSCOPY INSTRUMENT TYPE AND ACCESSORIES 51MARKET SIZE FOR OF ARTHROSCOPY ENDOSCOPY DEVICES 51TABLE 21 MARKET SIZE FOR OF ARTHROSCOPY DEVICES, THROUGH 2018 ($MILLIONS) 51MAJOR PLAYERS IN ARTHROSCOPY MARKET 51ENT ENDOSCOPY AND BRONCHOSCOPY 51ENT ENDOSCOPY 51NASAL SINOSCOPY 52TRANSNASAL RESECTION OF BRAIN-BASED CANCERS 52PEDICLED NASOSEPTAL FLAP PROTOCOL 53THROAT ENDOSCOPY 54Laryngoscopy 54Bronchoscopy 55Bronchoscope 55Thoracoscopy 55ENT AND BRONCHOSCOPY INSTRUMENT TYPE AND ACCESSORIES 56MARKET SIZE FOR ENT AND BRONCHOSCOPY DEVICES 56TABLE 22 MARKET SIZE FOR ENT AND BRONCHOSCOPY DEVICES, THROUGH 2018($ MILLIONS) 56MAJOR PLAYERS IN ENT AND BRONCHOSCOPY MARKET 57GYNECOLOGY ENDOSCOPY 57DIAGNOSTIC LAPAROSCOPY 57TUBAL STERILIZATION 57LYSIS OF ADHESION 58TREATMENT OF ENDOMETRIOSIS 58TREATMENT OF ECTOPIC PREGNANCY 58OVARIAN CYSTECTOMY 58HYSTERECTOMY 59ONCOLOGIC PROCEDURES 59GYNECOLOGY INSTRUMENT TYPE AND ACCESSORIES 59MARKET SIZE FOR GYNECOLOGY DEVICES 60TABLE 23 MARKET SIZE FOR GYNECOLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 60MAJOR PLAYERS IN GYNECOLOGY MARKET 60NEUROLOGY ENDOSCOPY 60HYDROCEPHALUS 61COLLOID CYST REMOVAL 61ARACHNOID CYST FENESTRATION 61NEUROCYSTICERCOSIS 62THORACIC AND LUMBAR DISC REMOVAL 62Lumbar Disc 62Thoracic Disc 63Minimally Invasive Sympathotomy 63Endoscopic Transthoracic Sympathotomy 64Upper Limb Sympathetic-mediated Pain 64ENDOSCOPE-ASSISTED SURGERIES 65NEUROLOGY INSTRUMENT TYPE AND ACCESSORIES 65MARKET SIZE FOR NEUROLOGY DEVICES 65TABLE 24 MARKET SIZE FOR NEUROLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 65MAJOR PLAYERS IN THE NEUROLOGY MARKET 66CHAPTER 5 GLOBAL ENDOSCOPY MARKET 68SUMMARY 68TABLE 25 TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($ MILLIONS) 68INTRODUCTION 68TABLE 26 GLOBAL DISTRIBUTION OF ENDOSCOPY REVENUE, 2011-2012 ($MILLIONS) 69INDIA 69CHINA 69JAPAN 70OVERALL ENDOSCOPY MARKET 70DRIVER OF ENDOSCOPY MARKET 71RESISTORS TO ENDOSCOPY MARKET 71MARKET SEGMENTS 72ENDOSCOPES 72Rigid Endoscopes 72Flexible Endoscopes 72ENDOSCOPIC ACCESSORIES 73VISUALIZATION EQUIPMENT 73ENDOSCOPY EQUIPMENT SERVICING 74CHAPTER 6 ADVANCES IN ENDOSCOPE TECHNOLOGY 76NARROW BAND IMAGING (NBI) 76HIGH-DEFINITION IMAGING AND HD TV 76THIRD EYE RETROSCOPE 76DOUBLE-BALLOON ENDOSCOPY DEVICE 76PILLCAM 77PICTURE ARCHIVING AND COMMUNICATIONS SYSTEM (PACS) 77NOTES 77ROBOT-ASSISTED ENDOSCOPY 78CHAPTER 7 ENDOSCOPY CLINICAL TRIALS WORLDWIDE 81CLINICAL TRIALS 81TABLE 27 ENDOSCOPY CLINICAL TRIALS WORLDWIDE 81CHAPTER 8 MERGERS AND ACQUISITIONS 99ACQUISITIONS 99TABLE 28 ACQUISITIONS IN THE GLOBAL ENDOSCOPY DEVICE MARKET, 2007-2012($ MILLIONS) 99PARTNERSHIPS 102TABLE 29 PARTNERSHIPS IN THE GLOBAL ENDOSCOPY DEVICE MARKET,2007-2012 102CHAPTER 9 COMPANY PROFILES OF MAJOR ENDOSCOPY MANUFACTURERS 107BOSTON SCIENTIFIC CORPORATION 107FINANCIAL PERFORMANCE 107TABLE 30 BOSTON SCIENTIFIC REVENUE PERFORMANCE, THROUGH 2012 ($MILLIONS) 107KEY SEGMENTS AND PRODUCT PORTFOLIO 108TABLE 31 BOSTON SCIENTIFIC PRODUCT PORTFOLIO 108GROWTH STRATEGIES 109SWOT ANALYSIS 109TABLE 32 BOSTON SCIENTIFIC SWOT ANALYSIS 109COVIDIEN 109FINANCIAL PERFORMANCE 110TABLE 33 COVIDIEN REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 110KEY SEGMENTS AND PRODUCT PORTFOLIO 110TABLE 34 COVIDIEN PRODUCT PORTFOLIO 110GROWTH STRATEGIES 111SWOT ANALYSIS 112TABLE 35 COVIDIEN SWOT ANALYSIS 112GIVEN IMAGING LTD. 112FINANCIAL PERFORMANCE 113TABLE 36 GIVEN IMAGING REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 113GROWTH STRATEGIES 113SWOT ANALYSIS 113TABLE 37 GIVEN IMAGING SWOT ANALYSIS 113JOHNSON & JOHNSON--ETHICON ENDO SURGERY (EES) 114FINANCIAL PERFORMANCE 114TABLE 38 ETHICON ENDO-SURGERY DEVICES REVENUE PERFORMANCE, THROUGH2012 ($ MILLIONS) 114KEY SEGMENTS AND PRODUCT PORTFOLIO 114TABLE 39 ETHICON ENDO SURGERY PRODUCT PORTFOLIO 115GROWTH STRATEGY 115SWOT ANALYSIS 116TABLE 40 ETHICON ENDO SURGERY SWOT ANALYSIS 116KARL STORZ GMBH & CO. KG 116FINANCIAL PERFORMANCE 117TABLE 41 KARL STORZ REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 117KEY SEGMENTS AND PRODUCT PORTFOLIO 117TABLE 42 KARL STORZ PRODUCT PORTFOLIO 117GROWTH STRATEGIES 118SWOT ANALYSIS 118TABLE 43 KARL STORZ SWOT ANALYSIS 118OLYMPUS MEDICAL SYSTEMS 119FINANCIAL PERFORMANCE 119TABLE 44 OLYMPUS MEDICAL SYSTEMS REVENUE PERFORMANCE, THROUGH20121 ($ MILLIONS) 119KEY SEGMENTS AND PRODUCT PORTFOLIO 119TABLE 45 OLYMPUS PRODUCT PORTFOLIO 120GROWTH STRATEGIES 120SWOT ANALYSIS 120TABLE 46 OLYMPUS MEDICAL SYSTEMS SWOT ANALYSIS 120SMITH & NEPHEW, INC. 121FINANCIAL PERFORMANCE 121TABLE 47 SMITH & NEPHEW REVENUE PERFORMANCE, THROUGH 2012 ($MILLIONS) 121KEY SEGMENTS AND PRODUCT PORTFOLIO 122TABLE 48 SMITH & NEPHEW PRODUCT PORTFOLIO 122GROWTH STRATEGIES 122SWOT ANALYSIS 122TABLE 49 SMITH & NEPHEW SWOT ANALYSIS 122STRYKER 123FINANCIAL PERFORMANCE 124TABLE 50 STRYKER REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 124KEY SEGMENTS AND PRODUCT PORTFOLIO 124TABLE 51 STRYKER PRODUCT PORTFOLIO 124GROWTH STRATEGIES 125SWOT ANALYSIS 127TABLE 52 STRYKER SWOT ANALYSIS 127HLC093B - Endoscopy Devices: Applications and Global MarketsCopyright (C) BCC Research, Wellesley MA USA, Website: .bccresearch.comLIST OF TABLESTABLE HEADING PAGE NO.SUMMARY TABLE TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($MILLIONS) 7TABLE 1 GLOBAL ENDOSCOPY REVENUES OF LEADING COMPANIES, THROUGH 2012($ MILLIONS) 11TABLE 2 LEADING PLAYERS IN VARIOUS ENDOSCOPY SEGMENTS 15TABLE 3 KIDNEY DISEASES COMMONLY MANAGED BY ENDOSCOPY 22TABLE 4 URETER DISEASES COMMONLY MANAGED BY ENDOSCOPY 22TABLE 5 BLADDER DISEASES COMMONLY MANAGED BY ENDOSCOPY 23TABLE 6 PROSTATE DISEASES COMMONLY MANAGED BY ENDOSCOPY 23TABLE 7 URETHRA DISEASES COMMONLY MANAGED BY ENDOSCOPY 23TABLE 8 MARKET SIZE FOR UROLOGICAL ENDOSCOPE DEVICES, THROUGH 2018 ($MILLIONS) 25TABLE 9 PENETRATION OF LAPAROSCOPY IN COMMON SURGICAL PROCEDURES INTHE U.S., 2012 (NUMBER/%) 28TABLE 10 COMMERCIALLY AVAILABLE MUCOSAL ABLATION THERAPY DEVICES 30TABLE 11 MARKET SIZE FOR LAPAROSCOPY DEVICES, THROUGH 2018 ($ MILLIONS) 31TABLE 12 KEY DEVICE TYPE FOR EMR PROCEDURE 35TABLE 13 KEY DEVICE CATEGORIES FOR ENDOSCOPIC ULTRASOUND 36TABLE 14 CLASSIFICATION OF STAINS USED IN CHROMOENDOSCOPY 39TABLE 15 COMMERCIALLY AVAILABLE SPRAY CATHETERS 40TABLE 16 MARKET SIZE FOR OF GI ENDOSCOPY DEVICES, THROUGH 2018 ($MILLIONS) 41TABLE 17 KNEE LIGAMENT DAMAGE AND SURGICAL REQUIREMENTS 44TABLE 18 PROCEDURES ROUTINELY EMPLOYED IN ARTHROSCOPIC ROTATOR CUFFSURGERY 46TABLE 19 COMMON CONDITIONS REQUIRING ARTHROSCOPIC WRIST SURGERY 47TABLE 20 SOME COMMON ELBOW DIAGNOSES REVEALED BY ARTHROSCOPICINVESTIGATION 49TABLE 21 MARKET SIZE FOR OF ARTHROSCOPY DEVICES, THROUGH 2018 ($MILLIONS) 51TABLE 22 MARKET SIZE FOR ENT AND BRONCHOSCOPY DEVICES, THROUGH 2018 ($MILLIONS) 56TABLE 23 MARKET SIZE FOR GYNECOLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 60TABLE 24 MARKET SIZE FOR NEUROLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 65TABLE 25 TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($ MILLIONS) 68TABLE 26 GLOBAL DISTRIBUTION OF ENDOSCOPY REVENUE, 2011-2012 ($ MILLIONS) 69TABLE 27 ENDOSCOPY CLINICAL TRIALS WORLDWIDE 81TABLE 28 ACQUISITIONS IN THE GLOBAL ENDOSCOPY DEVICE MARKET, 2007-2012($ MILLIONS) 99TABLE 29 PARTNERSHIPS IN THE GLOBAL ENDOSCOPY DEVICE MARKET, 2007-2012 102TABLE 30 BOSTON SCIENTIFIC REVENUE PERFORMANCE, THROUGH 2012 ($MILLIONS) 107TABLE 31 BOSTON SCIENTIFIC PRODUCT PORTFOLIO 108TABLE 32 BOSTON SCIENTIFIC SWOT ANALYSIS 109TABLE 33 COVIDIEN REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 110TABLE 34 COVIDIEN PRODUCT PORTFOLIO 110TABLE 35 COVIDIEN SWOT ANALYSIS 112TABLE 36 GIVEN IMAGING REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 113TABLE 37 GIVEN IMAGING SWOT ANALYSIS 113HLC093B - Endoscopy Devices: Applications and Global MarketsCopyright (C) BCC Research, Wellesley MA USA, Website: .bccresearch.comTABLE HEADING PAGE NO.TABLE 38 ETHICON ENDO-SURGERY DEVICES REVENUE PERFORMANCE, THROUGH2012 ($ MILLIONS) 114TABLE 39 ETHICON ENDO SURGERY PRODUCT PORTFOLIO 115TABLE 40 ETHICON ENDO SURGERY SWOT ANALYSIS 116TABLE 41 KARL STORZ REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 117TABLE 42 KARL STORZ PRODUCT PORTFOLIO 117TABLE 43 KARL STORZ SWOT ANALYSIS 118TABLE 44 OLYMPUS MEDICAL SYSTEMS REVENUE PERFORMANCE, THROUGH 20121($ MILLIONS) 119TABLE 45 OLYMPUS PRODUCT PORTFOLIO 120TABLE 46 OLYMPUS MEDICAL SYSTEMS SWOT ANALYSIS 120TABLE 47 SMITH & NEPHEW REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 121TABLE 48 SMITH & NEPHEW PRODUCT PORTFOLIO 122TABLE 49 SMITH & NEPHEW SWOT ANALYSIS 122TABLE 50 STRYKER REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 124TABLE 51 STRYKER PRODUCT PORTFOLIO 124TABLE 52 STRYKER SWOT ANALYSIS 127HLC093B - Endoscopy Devices: Applications and Global MarketsCopyright (C)To order this report:General_Medicine_and_Specialty_Medicine Industry: Endoscopy Devices: Applications and Global MarketsContact Clare: clare@reportlinker.com US:(339) 368 6001 Intl:+1 339 368 6001ReportlinkerWeb site: .reportlinker.com/新蒲崗迷你倉
留言列表
